T. Buniva

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

Alfredo Berruti, Marco Tampellini, M. Torta et al. · European Journal of Cancer · 1994 · 85 citations

Prognostic Evaluation, Breast Oncology, Ca 125 +9

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease

Marco Tampellini, Alfredo Berruti, Aldo Gerbino et al. · British Journal of Cancer · 1997 · 82 citations · Full text

Breast Oncology, Cancer Risk, Breast Cancer Patients +7

Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.

Luigi Dogliotti, Alfredo Berruti, T. Buniva et al. · Journal of Clinical Oncology · 1996 · 50 citations

Melatonin and human cancer

Luigi Dogliotti, Alfredo Berruti, T. Buniva et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1990 · 31 citations

Medicine, Pathology, Human Cancer +4

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival.

Alfredo Berruti, Paolo Zola, T. Buniva et al. · PubMed · 1997 · 25 citations

Prognostic Factors, Breast Oncology, Oncology +12